WASHINGTON (dpa-AFX) - Medical technology company BD or Becton, Dickinson
and Co. (BDX) announced Friday the global commercial release of new cell sorters
that will enable more researchers in a broader range of fields, including cell
biology, cancer research and immunology, to reveal insights that were previously
invisible in traditional flow cytometry experiments.

The new BD FACSDiscover S8 Cell Sorters feature BD CellView Image Technology,
profiled on the cover of the journal Science in 2022, and BD SpectralFX
Technology - bringing to market breakthrough innovations in real-time imaging
and spectral flow cytometry.

The three- and four-laser additions to the BD FACSDiscover S8 Cell Sorter family
complement the five-laser instrument launched last year and provide scientists
greater access, options, and flexibility to incorporate real-time imaging and
spectral cell sorting technology in their labs.

Using the FACSDiscover S8 Cell Sorters, researchers can confirm complex
biological and spatial insights in real time, obtain individual cell images and
isolate desired cells based on visual characteristics at high speeds, all within
a simplified and easy to use workflow.

BD CellView Image Technology improves sort and sample quality, bringing
confidence to biological results and saving researchers time and cost in their
downstream applications.

This expedited time to insight expands capabilities for researchers to transform
research and cell-based therapeutic development across numerous fields in drug
discovery, immuno-oncology and genomics.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX